Impact of biospecimens handling on biomarker research in breast cancer

BMC Cancer

Volumn 9, Issue , 2009, Pages

  De Cecco, Loris ^a   Musella, Valeria ^b   Veneroni, Silvia ^b   Cappelletti, Vera ^b   Bongarzone, Italia ^b   Callari, Maurizio ^b   Valeri, Barbara ^b   Pierotti, Marco A ^b   Daidone, Maria G ^b  

^a FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^b NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER; MESSENGER RNA;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; MEDICAL RESEARCH; MICROARRAY ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TEMPERATURE; TISSUE SECTION; UPREGULATION; BREAST TUMOR; DNA MICROARRAY; FREEZING; GENETICS; LABORATORY DIAGNOSIS; METHODOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STANDARD; TIME;

BIOMEDICAL RESEARCH; BREAST NEOPLASMS; FEMALE; FREEZING; GENE EXPRESSION PROFILING; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECIMEN HANDLING; TIME; TUMOR MARKERS, BIOLOGICAL;

EID: 71549121346     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-9-409     Document Type: Article

References (39)

1. Brennan DJ, Kelly C, Rexhepaj E, Dervan PA, Duffy MJ, Gallagher WM. Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalized medicine in breast cancer. Cancer Genomics Proteomics 2007, 4:121-134.
2. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T, Hiller W, Fisher ER, Wickerham DL, Bryant J, Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer patients. New Engl J Med 2004, 351:2817-2826. 10.1056/NEJMoa041588, 15591335.
3. Almeida A, Paul Thiery J, Magdelénat H, Radvanyi F. Gene expression analysis by real-time reverse transcription polymerase chain reaction: influence of tissue handling. Anala Biochem 2004, 328:101-108.
4. Spruessel A, Steimann G, Jung M, Lee SA, Carr T, Fentz AK, Spangenberg J, Zornig C, Juhl HH, David KA. Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. Biotechniques 2004, 36:1030-1037.
5. Mager SR, Oomen MH, Morente MM, Ratcliffe C, Knox K, Kerr DJ, Pezzella F, Riegman PH. Standard operating procedure for the collection of fresh frozen tissue samples. Eur J Cancer 2007, 43:828-834. 10.1016/j.ejca.2007.01.002, 17329097.
6. Huang J, Qi R, Quackenbush J, Dauway E, Lazaridis E, Yeatman T. Effects of ischemia on gene expression. J Surg Res 2001, 99:222-227. 10.1006/jsre.2001.6195, 11469890.
7. Blackhall FH, Pintilie M, Wigle DA, Jurisica I, Liu N, Radulovich N, Johnston MR, Keshavjee S, Tsao MS. Stability and heterogeneity of expression profiles in lung cancer specimens harvested following surgical resection. Neoplasia 2004, 6:761-767. 10.1593/neo.04301, 1531680, 15720802.
8. Dash A, Maine IP, Varambally S, Shen R, Chinnaiyan AM, Rubin MA. Changes in differential gene expression because of warm ischemia time of radical prostatectomy specimens. Am J Pathol 2002, 161:1743-1748. 1850797, 12414521.
9. Miyatake Y, Ikeda H, Michimata R, Koizumi S, Ishizu A, Nishimura N, Yoshiki T. Differential modulation of gene expression among rat tissues with warm ischemia. Exp Mol Pathol 2004, 77:222-230. 10.1016/j.yexmp.2004.07.004, 15507240.
10. Haibe-Kains B, Desmedt C, Piette F, Buyse M, Cardoso F, Van't Veer L, Piccart M, Bontempi G, Sotiriou C. Comparison of Prognostic Gene Expression signatures for Breast Cancer. BMC Genomics 2008, 9:394. 10.1186/1471-2164-9-394, 2533026, 18717985.
11. Cappelletti V, Gariboldi M, De Cecco L, Toffanin S, Reid JF, Lusa L, Bajetta E, Celio L, Greco M, Fabbri A, Pierotti MA, Daidone MG. Patterns and changes in gene expression following neo-adjuvant anti-estrogen treatment in estrogen receptor-positive breast cancer. Endocr Relat Cancer 2008, 15:439-449. 10.1677/ERC-07-0274, 18508997.
12. Gorla L, Cantu M, Miccichè F, Patelli C, Mondellini P, Pierotti MA, Bongarzone I. RET oncoproteins induce tyrosine phosphorylation changes of proteins involved in RNA metabolism. Cell Signal 2006, 18:2272-2282. 10.1016/j.cellsig.2006.05.016, 16843637.
13. Saal LH, Troein C, Vallon-Christersson J, Gruvberger S, Borg A, Peterson C. BioArray Software Environment (BASE): A Platform for Comprehensive Management and Analysis of Microarray Data. Genome Biology 2002, 3:software0003.1-0003.6.
14. Yang YH, Dudoit S, Luu P, Lin DM, Peng V, Ngai J, Speed TP. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res 2002, 3:e15.
15. Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y. Analysis of Gene Expression Data Using BRB-Array Tools. Cancer Informatics 2007, 3:11-17. 2675854, 19455231.
16. Diehn M, Sherlock G, Binkley G, Jin H, Metese JC, Hernandez-Boussard T, Rees CA, Cherry JM, Botstein D, Brown PO, Alizadeh AA. SOURCE: a unified genomic resource of functional annotations, ontologies, and gene expression data. Nucleic Acids Res 2003, 31:219-223. 10.1093/nar/gkg014, 165461, 12519986.
17. Bussey KJ, Kane D, Sunshine M, Narasimhan S, Nishizuka S, Reinhold WC, Zeeberg B, Ajay W, Weinstein JN. MatchMiner: a tool for batch navigation among gene and gene product identifiers. Genome Biology 2003, 4:R27. 10.1186/gb-2003-4-4-r27, 154578, 12702208.
18. Beekman JM, Reischl J, Henderson D, Bauer D, Ternes R, Peña C, Lathia C, Heubach JF. Recovery of microarray-quality RNA from frozen EDTA blood samples. J Pharmacol Toxicol Methods 2009, 59:44-49. 10.1016/j.vascn.2008.10.003, 19028589.
19. Fleige S, Walf V, Huch S, Prgomet C, Sehm J, Pfaffl MW. Comparison of relative mRNA quantification models and the impact of RNA integrity in quantitative real-time RT-PCR. Biotechnol Lett 2006, 28:1601-1613. 10.1007/s10529-006-9127-2, 16900335.
20. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J Roy Stat Soc, Ser B 1995, 57:289-300.
21. Rommel C, Camps M, Ji H. PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?. Nat Rev Immunol 2007, 3:191-201.
22. Lee KS, Park SJ, Kim SR, Min KH, Jin SM, Puri KD, Lee YC. Phosphoinositide 3-kinase-delta inhibitor reduces vascular permeability in a murine model of asthma. J Allergy Clin Immunol 2006, 118:403-9. 10.1016/j.jaci.2006.04.041, 16890765.
23. Ivanov SV, Salnikow K, Ivanova AV, Bai L, Lerman MI. Hypoxic repression of STAT1 and its downstream genes by a pVHL/HIF-1 target DEC1/STRA13. Oncogene 2007, 26:802-12. 10.1038/sj.onc.1209842, 16878149.
24. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Puré E, Agami R. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10:202-210. 10.1038/ncb1681, 18193036.
25. Diaz LK, Zhou X, Wright ET, Cristofanilli M, Smith T, Yang Y, Sneige N, Sahin A, Gilcrease MZ. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma. Clin Cancer Res 2005, 11:3309-3314. 10.1158/1078-0432.CCR-04-2184, 15867228.
26. Lopez JI, Camenisch TD, Stevens MV, Sands BJ, McDonald J, Schroeder JA. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Res 2005, 65:6755-6763. 10.1158/0008-5472.CAN-05-0863, 16061657.
27. Meijer D, Sieuwerts AM, Look MP, van Agthoven T, Foekens JA, Dorssers LC. Fibroblast growth factor receptor 4 predicts failure on tamoxifen therapy in patients with recurrent breast cancer. Endocr Relat Cancer 2008, 15:101-111. 10.1677/ERC-07-0080, 18310279.
28. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Eystein Lønning P, Børresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumour subclasses with clinical implications. Proc Natl Acad Sci 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
29. Loi S, Haibe-Kains B, Desmedt C, Lallemand F, Tutt AM, Gillet C, Ellis P, Harris A, Bergh J, Foekens JA, Klijn JG, Larsimont D, Buyse M, Bontempi G, Delorenzi M, Piccart MJ, Sotiriou C. Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade. J Clin Oncol 2007, 25:1239-1246. 10.1200/JCO.2006.07.1522, 17401012.
30. Chang HY, Sneddon JB, Alizadeh AA, Sood R, West RB, Montgomery K, Chi JT, Rijn M, Botstein D, Brown PO. Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol 2004, 2:E7. 10.1371/journal.pbio.0020007, 314300, 14737219.
31. Ivshina AV, George J, Senko O, Mow B, Putti TC, Smeds J, Lindahl T, Pawitan Y, Hall P, Nordgren H, Wong JE, Liu ET, Bergh J, Kuznetsov VA, Miller LD. Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer. Cancer Res 2006, 66:10292-10301. 10.1158/0008-5472.CAN-05-4414, 17079448.
32. van't Veer LJ, Dai H, Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, Kooy K, Marton MJ, Witteveen AT, Schreiber GJ, Kerkhoven RM, Roberts C, Linsley PS, Bernards R, Friend SH. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536. 10.1038/415530a, 11823860.
33. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, Livasy C, Carey LA, Reynolds E, Dressler L, Nobel A, Parker J, Ewend MG, Sawyer LR, Wu J, Liu Y, Nanda R, Tretiakova M, Ruiz Orrico A, Dreher D, Palazzo JP, Perreard L, Nelson E, Mone M, Hansen H, Mullins M, Quackenbush JF, Ellis MJ, Olopade OI, Bernard PS, Perou CM. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006, 7:96. 10.1186/1471-2164-7-96, 1468408, 16643655.
34. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, Talantov D, Timmermans M, Meijer-van Gelder ME, Yu J, Jatkoe T, Berns EM, Atkins D, Foekens JA. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005, 365:671-679.
35. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. J Clin Oncol 2006, 24:3726-3734. 10.1200/JCO.2005.04.7985, 16720680.
36. Stoner M, Saville B, Wormke M, Dean D, Burghardt R, Safe S. Hypoxia induces proteasome-dependent degradation of estrogen receptor alpha in ZR-75 breast cancer cells. Mol Endocrinol 2002, 16:2231-2242. 10.1210/me.2001-0347, 12351689.
37. Cooper C, Liu GY, Niu YL, Santos S, Murphy LC, Watson PH. Intermittent hypoxia induces proteasome-dependent down-regulation of estrogen receptor alpha in human breast carcinoma. Clin Cancer Res 2004, 10:8720-8727. 10.1158/1078-0432.CCR-04-1235, 15623657.
38. Helczynska K, Kronblad A, Jogi A, Nilsson E, Beckman S, Landberg G, Palman S. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003, 63:1441-1444.
39. Bos R, Zhong H, Hanrahan CF, Mommers EC, Semenza GL, Pinedo HM, Abeloff MD, Simons JW, van Diest PJ, Wall E. Levels of hypoxia-inducible factor-1 alpha during breast carcinogenesis. J Natl Cancer Inst 2001, 93:309-314. 10.1093/jnci/93.4.309, 11181778.